RESULTS OF A PHASE 2B CLINICAL TRIAL OF TC-5619, A SELECTIVE ALPHA 7 NEURONAL NICOTINIC RECEPTOR (NNR) AGONIST, IN THE ADJUNCTIVE TREATMENT OF NEGATIVE SYMPTOMS AND COGNITIVE DYSFUNCTION IN SCHIZOPHRENIA

✍ Scribed by Hosford, David

• Book ID: 121775670
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 106 KB
• Volume: 153
• Category: Article
• ISSN: 0920-9964
• DOI: 10.1016/S0920-9964(14)70067-2